NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme

David M. Peereboom; Manmeet S. Ahluwalia; Xiaobu Ye; Jeffrey G. Supko; Sarah L. Hilderbrand; Surasak Phuphanich; L. Burt Nabors; Myrna R. Rosenfeld; Tom Mikkelsen; Stuart A. Grossman

doi:10.1093/NEUONC/NOS322

NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme

David M. Peereboom, Manmeet S. Ahluwalia, Xiaobu Ye, Jeffrey G. Supko, Sarah L. Hilderbrand, Surasak Phuphanich, L. Burt Nabors, Myrna R. Rosenfeld, Tom Mikkelsen, Stuart A. Grossman

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	15
DOIs	https://doi.org/10.1093/NEUONC/NOS322
State	Published - Apr 1 2013

Disciplines

Pharmacology
Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1093/NEUONC/NOS322License: Unspecified

Cite this

@article{7228951b4a7841b9aa6100f0ec4bdd25,

title = "NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme",

author = "Peereboom, \{David M.\} and Ahluwalia, \{Manmeet S.\} and Xiaobu Ye and Supko, \{Jeffrey G.\} and Hilderbrand, \{Sarah L.\} and Surasak Phuphanich and Nabors, \{L. Burt\} and Rosenfeld, \{Myrna R.\} and Tom Mikkelsen and Grossman, \{Stuart A.\}",

note = "NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme.",

year = "2013",

month = apr,

day = "1",

doi = "10.1093/NEUONC/NOS322",

language = "American English",

volume = "15",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme

AU - Peereboom, David M.

AU - Ahluwalia, Manmeet S.

AU - Ye, Xiaobu

AU - Supko, Jeffrey G.

AU - Hilderbrand, Sarah L.

AU - Phuphanich, Surasak

AU - Nabors, L. Burt

AU - Rosenfeld, Myrna R.

AU - Mikkelsen, Tom

AU - Grossman, Stuart A.

N1 - NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme.

PY - 2013/4/1

Y1 - 2013/4/1

UR - http://europepmc.org/articles/PMC3607264

U2 - 10.1093/NEUONC/NOS322

DO - 10.1093/NEUONC/NOS322

M3 - Article

VL - 15

JO - Neuro-oncology

JF - Neuro-oncology

ER -

NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme

Disciplines

Access to Document

Other files and links

Cite this